Shandong Sinobioway Biomedicine Co.,Ltd. Posted 50.9 Million Yuan Net Loss in First Half of 2023

Shandong Sinobioway Biomedicine Co.,Ltd. (山东未名生物医药股份有限公司) (002581.SZ) reported a net loss of 50.9 million yuan in the first half of 2023, reversing a net profit of 29.2 million yuan for the same period in the previous year.

Meanwhile, the company posted 209.2 million yuan in revenue, up 11.5% year-on-year.

At the end of the reporting period, it had 2.7 billion yuan in total assets and 329.5 million yuan in total liabilities, with a liability-to-asset ratio of 12%.